ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Karolinska Development Ab

Karolinska Development Ab (0P3C)

6.50
0.00
(0.00%)
Closed November 04 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
6.50
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
6.50 52 Week Range 6.50
Market Cap
Previous Close
6.50
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
267,522,000
Dividend Yield
-
PE Ratio
323.38
Earnings Per Share (EPS)
0.02
Revenue
2.01M
Net Profit
5.39M

About Karolinska Development Ab

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Headquarters
Solna, Swe
Founded
-
Karolinska Development Ab is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker 0P3C. The last closing price for Karolinska Development Ab was SEK6.50. Over the last year, Karolinska Development Ab shares have traded in a share price range of SEK 6.50 to SEK 6.50.

Karolinska Development Ab currently has 267,522,000 shares outstanding. The market capitalization of Karolinska Development Ab is SEK1.74 billion. Karolinska Development Ab has a price to earnings ratio (PE ratio) of 323.38.

0P3C Latest News

Karolinska Development’s portfolio company SVF Vaccines announces positive data from a phase 1 study of its universal Covid-19 vaccine

Karolinska Development’s portfolio company SVF Vaccines announces positive data from a phase 1 study of its universal Covid-19 vaccine STOCKHOLM, SWEDEN, October 21, 2024. Karolinska Development...

Karolinska Development’s portfolio company Umecrine Cognition presents new preclinical Parkinson’s data on golexanolone at the scientific conference, INBC 2024

Karolinska Development’s portfolio company Umecrine Cognition presents new preclinical Parkinson’s data on golexanolone at the scientific conference, INBC 2024 STOCKHOLM, SWEDEN – October 17...

Notice of Extraordinary General Meeting in Karolinska Development AB (publ)

Notice of Extraordinary General Meeting in Karolinska Development AB (publ) The shareholders of Karolinska Development AB (publ), reg. no. 556707-5048, (“Karolinska Development” or the “Company”...

Karolinska Development divests its holding in the Danish dermatology company Henlez

Karolinska Development divests its holding in the Danish dermatology company Henlez STOCKHOLM, SWEDEN, September 23 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces the...

Karolinska Development’s portfolio company AnaCardio reports progress in two clinical trials with its drug candidate AC01

Karolinska Development’s portfolio company AnaCardio reports progress in two clinical trials with its drug candidate AC01 STOCKHOLM, SWEDEN September 17, 2024. Karolinska Development AB (Nasdaq...

Karolinska Developments portfolio company BOOST Pharma announces positive top-line results from a Phase 1/2 study with over 75% reduction of fracture rates in children with rare bone disease

Karolinska Developments portfolio company BOOST Pharma announces positive top-line results from a Phase 1/2 study with over 75% reduction of fracture rates in children with rare bone disease...

Karolinska Development’s portfolio company Biosergen announces successful treatment of first patient in a clinical trial of BSG005

Karolinska Development’s portfolio company Biosergen announces successful treatment of first patient in a clinical trial of BSG005 STOCKHOLM, Sweden, August 30 2024. Karolinska Development AB...

Interim Report - January-June 2024

Interim Report - January-June 2024 STOCKHOLM – 30 August 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report - January-June 2024. The full report is...

Karolinska Development’s portfolio company PharmNovo receives EUR 17.5 million from the innovation program EIC Accelerator

Karolinska Development’s portfolio company PharmNovo receives EUR 17.5 million from the innovation program EIC Accelerator STOCKHOLM, SWEDEN – July 16, 2024. Karolinska Development AB (Nasdaq...

Karolinska Development’s portfolio company Umecrine Cognition secures funding for continued clinical development of golexanolone

Karolinska Development’s portfolio company Umecrine Cognition secures funding for continued clinical development of golexanolone STOCKHOLM, SWEDEN – July 10, 2024. Karolinska Development AB...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1006.56.56.500DE
4006.56.56.500DE
12006.56.56.500DE
26006.56.56.52856.5DE
52006.56.56.52216.5DE
156006.56.56.57056.5DE
260006.56.56.56316.5DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AFCAfc Energy Plc
10.60p
(30.86%)
23.62M
CPH2Clean Power Hydrogen Plc
10.25p
(24.24%)
2.33M
BAFBritish & American Investment Trust Plc
34.00p
(24.09%)
147.85k
ROQRoquefort Therapeutics Plc
6.25p
(19.05%)
5.72M
BMNBushveld Minerals Limited
0.475p
(18.75%)
24.22M
FDBKFeedback Plc
24.50p
(-44.94%)
785.05k
ACPArmadale Capital Plc
0.06p
(-20.00%)
5.67M
PRDPredator Oil & Gas Holdings Plc
5.75p
(-17.86%)
6.4M
0R2VApple Inc
$ 190.00
(-14.61%)
2.38M
PIPPipehawk Plc
1.35p
(-12.90%)
160.59k
NTVONativo Resources Plc
0.0027p
(8.00%)
2.31B
MSMNMosman Oil And Gas Limited
0.039p
(4.00%)
655.03M
UOGUnited Oil & Gas Plc
0.31p
(16.98%)
372.31M
TRPTower Resources Plc
0.03p
(-1.64%)
291.03M
CPXCap-xx Limited
0.1425p
(9.62%)
254.82M

Discussion

View Full Feed
kthomp19 kthomp19 2 minutes ago
To make my point requires zero money, the same as for you to make yours.

Nope, it doesn't work that way at all. If you were so convinced that the LP ratchet really did breach the implied covenant then you would put some skin in the game and file the lawsuit yourself.

My
FNMA
kthomp19 kthomp19 2 minutes ago
*sighs while tapping the sign again*

I provided links to court opinions and HERA. You gave empty generalities with no logic behind them. Declare victory all you want, you still lost.

they can dissolve the entities

This is your biggest lie yet. The entitie
FNMA
BigBadWolf BigBadWolf 2 minutes ago
Absolutely as I posted it the day it became official 10/23/24
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175275607&txt2find=official
ASII
ducci1 ducci1 2 minutes ago
Covered 1/2 570P .84!--- Daily Double on The Flip !
SPY
Steady_T Steady_T 2 minutes ago
The mabs are very different from DCVax-L. Not really a good comparison.
AVXL
MightyX MightyX 3 minutes ago
Real OTC-investors understand limited-communication is inherent-risk of OTC.
TPTW
Flobewan Flobewan 3 minutes ago
Hey try one of these and let me know, LOL

https://www.youtube.com/watch?v=ZhwBnn7Q-sc
thesmallguy thesmallguy 3 minutes ago
peeps? Or me? Peeps were delighted this morning by the news of an acquisition and many expected 100% today. I, personally, think the news is great and today is waaay oversold. I was hoping for a .0008 close, but that looks impossible now.

Everyone on this board knew the AS was go
ASII
Hitman970 Hitman970 3 minutes ago
THE WAIT IS OVER!!!$$$
AASP
PatB1 PatB1 3 minutes ago
After today's performance?  Highly doubt it! Company has proven they are a sham, just like every other pinky out there! Pump and dump! Rinse! Repeat! POS!!!
ASII
NorCalTommy NorCalTommy 3 minutes ago
Hey NavyHusker- don't be so sure our new GX SPAC Shark Board Members are not contributing greatly to our cause....... heck, behind the scenes they are probably letting Mark and Jim borrow their yachts and summer/winter vacation homes..... doesn't that count for anything? even tho they did get a 'GAW
NB
RobotDroid RobotDroid 4 minutes ago
Best to not suffer fools and put that moron on ignore. He is drowning in the koolaid.
NWBO
GolfFishSurf GolfFishSurf 4 minutes ago
Anyone expecting a big beat, or something close the the analyst projections?
PLTR
sloppyjones sloppyjones 4 minutes ago
Like EM, then EM again, and again... You mean that correlation to why the pps is here?
TPTW
vinmantoo vinmantoo 4 minutes ago
I do think there is a debate about weather Viking can make VK2735 at scale competitively cause its a peptide large molecule. I'm going to repeat my earlier investment thesis on this point which is basically Brian Lian is not an idiot. He has a PhD in Organic Chemistry,, has a great business sense an
PARker1703 PARker1703 4 minutes ago
Tons more shares to trade this week,,,,. 11 cents buy Friday 
NWBO
CommodityCoverage CommodityCoverage 4 minutes ago
Gold has surged in 2024, rising around 35% since January and reaching nearly $2,800 per ounce in November, driven by its role as an inflation hedge and a portfolio diversifier. With inflation, interest rates, geopolitical tensions, and an impending U.S. presidential election influencing the market,
BOGO
JTORENCE JTORENCE 4 minutes ago
Down again on unusually heavy volume.
NWBO
janice shell janice shell 4 minutes ago
If he wins, he won't be able to con any more money from the gullible.

A point I hadn't considered.
carlson carlson 4 minutes ago
Do you think we'll close at HOD?
NBRI
Groveman1 Groveman1 5 minutes ago
Question is, who is buying or selling 2 million shares for a total of $2.38 ???????? Odd!
LLBO
getmoreshares getmoreshares 5 minutes ago
VERY GOOD!!! LMDO!!!!!
lakers17 lakers17 5 minutes ago
Hilarious. Charts don't work in the OTC and in stocks like NBRI. It's all events, PRs and filings. You made all your money early 2021 in the OTC as we all did. Everything went up and I mean everything for those 3 months. Had zero to do with charts. What did you make in 2022 and 2023 in the OTC
NBRI
burner67 burner67 5 minutes ago
I'm just waiting for November 15th
BEGI

Your Recent History

Delayed Upgrade Clock